Aerosolized ribavirin: the most expensive drug for pneumonia

How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation

(2016) A. Waghmare et al.   BLOOD

Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative

(2016) O.E. Beaird et al.   Transplant Infectious Disease

Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections

(2014) D. P. Shah et al.   BLOOD

Management of Respiratory Viral Infections in Hematopoietic Cell Transplant Recipients and Patients With Hematologic Malignancies

(2014) Roy F. Chemaly et al.   CLINICAL INFECTIOUS DISEASES

Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients

(2014) J.R. Marcelin et al.   Transplant Infectious Disease

High Cancer Drug Prices in the United States: Reasons and Proposed Solutions

(2014) Hagop Kantarjian et al.   Journal of Oncology Practice

Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation

(2013) J Casey et al.   BONE MARROW TRANSPLANTATION

Respiratory Syncytial Virus Lower Respiratory Disease in Hematopoietic Cell Transplant Recipients: Viral RNA Detection in Blood, Antiviral Treatment, and Clinical Outcomes

(2013) Alpana Waghmare et al.   CLINICAL INFECTIOUS DISEASES

Efficacy of Oral Ribavirin in Hematologic Disease Patients with Paramyxovirus Infection: Analytic Strategy Using Propensity Scores

(2012) S.-Y. Park et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Costs of autologous and allogeneic hematopoietic cell transplantation in the United States: a study using a large National Private Claims Database

(2012) N S Majhail et al.   BONE MARROW TRANSPLANTATION